ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Delivery System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-27Z8927
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gene Delivery System Market Size Status and Forecast 2022
BUY CHAPTERS

Global Gene Delivery System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-27Z8927
Report
August 2025
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen Inc
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
Sibiono
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Novartis
Biogen
Adaptimmune
Krystal Biotech
Vertex Pharmaceuticals
CSL Behring

Gene Delivery System Sales Market Size

The global Gene Delivery System market size was US$ 11480 million in 2024 and is forecast to a readjusted size of US$ 61870 million by 2031 with a CAGR of 27.6% during the forecast period 2025-2031.

Gene Delivery System Sales Market

Gene Delivery System Sales Market

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The gene delivery system market is experiencing rapid growth, primarily driven by advancements in gene therapy, personalized medicine, and biotechnology research. The increasing prevalence of genetic disorders, cancers, and rare diseases has fueled demand for targeted and effective gene-based treatments. Innovations in delivery vectors—such as viral systems (adenoviral, lentiviral) and non-viral methods (lipid nanoparticles, polymers, and electroporation)—are enabling more precise and efficient gene delivery. Additionally, the success of mRNA-based COVID-19 vaccines has accelerated investment and trust in nucleic acid delivery platforms. Supportive regulatory policies, increased R&D funding from both government and private sectors, and rising collaborations between pharmaceutical companies and academic institutions are further boosting the global gene delivery market.
Despite significant advancements, the gene delivery system market faces several complex challenges. One major hurdle is ensuring safe, efficient, and tissue-specific delivery of genetic material without triggering immune responses or toxicity. Viral vectors, while effective, can carry risks such as insertional mutagenesis or immunogenicity, limiting their long-term application. Non-viral vectors, on the other hand, often face limitations in transfection efficiency and stability. Manufacturing scalability and quality control also remain problematic, especially for complex delivery systems. Moreover, the high cost of gene therapies and the limited availability of clinical-grade vectors pose barriers to broader adoption, particularly in low- and middle-income countries. Navigating diverse regulatory frameworks globally adds another layer of complexity for companies operating across borders.
The global Gene Delivery System market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation

Scope of Gene Delivery System Sales Market Report

Report Metric Details
Report Name Gene Delivery System Sales Market
Forecasted market size in 2031 US$ 61870 million
CAGR 27.6%
Forecasted years 2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)
  • Viral Gene Delivery System
  • Non-viral Gene Delivery System
By Application: (Core Demand Driver vs Emerging Opportunity)
  • Neurological Diseases
  • Cancer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company: Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute, Adaptimmune, Krystal Biotech, Vertex Pharmaceuticals, CSL Behring
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
  • Chapter 2: Quantitative analysis of Gene Delivery System market size and growth potential at global, regional, and country levels.
  • Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
  • Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Non-viral Gene Delivery System in China).
  • Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cancer in India).
  • Chapter 6: Regional revenue breakdown by company, type, application and customer.
  • Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
  • Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 9: Actionable conclusions and strategic recommendations.
  • Why This Report?
  • Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Gene Delivery System value chain, addressing:

FAQ for this report

What is the Gene Delivery System Sales Market size in 2031?

Ans: The Gene Delivery System Sales Market size in 2031 will be US$ 61870 million.

Who are the main players in the Gene Delivery System Sales Market report?

Ans: The main players in the Gene Delivery System Sales Market are Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute, Adaptimmune, Krystal Biotech, Vertex Pharmaceuticals, CSL Behring

What are the Application segmentation covered in the Gene Delivery System Sales Market report?

Ans: The Applications covered in the Gene Delivery System Sales Market report are Neurological Diseases, Cancer, Others

What are the Type segmentation covered in the Gene Delivery System Sales Market report?

Ans: The Types covered in the Gene Delivery System Sales Market report are Viral Gene Delivery System, Non-viral Gene Delivery System

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Delivery System Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Gene Delivery System Revenue Market Share by Region (2020-2025)
2.4 Global Gene Delivery System Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Gene Delivery System Market Size and Prospective (2020-2031)
2.5.2 Europe Gene Delivery System Market Size and Prospective (2020-2031)
2.5.3 China Gene Delivery System Market Size and Prospective (2020-2031)
2.5.4 Japan Gene Delivery System Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Gene Delivery System Historic Market Size by Type (2020-2025)
3.2 Global Gene Delivery System Forecasted Market Size by Type (2026-2031)
3.3 Different Types Gene Delivery System Representative Players
4 Breakdown Data by Application
4.1 Global Gene Delivery System Historic Market Size by Application (2020-2025)
4.2 Global Gene Delivery System Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Gene Delivery System Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Gene Delivery System Players by Revenue (2020-2025)
5.1.2 Global Gene Delivery System Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Gene Delivery System Revenue
5.4 Global Gene Delivery System Market Concentration Analysis
5.4.1 Global Gene Delivery System Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Gene Delivery System Revenue in 2024
5.5 Global Key Players of Gene Delivery System Head office and Area Served
5.6 Global Key Players of Gene Delivery System, Product and Application
5.7 Global Key Players of Gene Delivery System, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Gene Delivery System Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Gene Delivery System Market Size by Type (2020-2025)
6.1.2.2 North America Gene Delivery System Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Gene Delivery System Market Size by Application (2020-2025)
6.1.3.2 North America Gene Delivery System Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Gene Delivery System Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Gene Delivery System Market Size by Type (2020-2025)
6.2.2.2 Europe Gene Delivery System Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Gene Delivery System Market Size by Application (2020-2025)
6.2.3.2 Europe Gene Delivery System Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Gene Delivery System Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Gene Delivery System Market Size by Type (2020-2025)
6.3.2.2 China Gene Delivery System Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Gene Delivery System Market Size by Application (2020-2025)
6.3.3.2 China Gene Delivery System Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Gene Delivery System Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Gene Delivery System Market Size by Type (2020-2025)
6.4.2.2 Japan Gene Delivery System Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Gene Delivery System Market Size by Application (2020-2025)
6.4.3.2 Japan Gene Delivery System Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Biogen
7.1.1 Biogen Company Details
7.1.2 Biogen Business Overview
7.1.3 Biogen Gene Delivery System Introduction
7.1.4 Biogen Revenue in Gene Delivery System Business (2020-2025)
7.1.5 Biogen Recent Development
7.2 Novartis
7.2.1 Novartis Company Details
7.2.2 Novartis Business Overview
7.2.3 Novartis Gene Delivery System Introduction
7.2.4 Novartis Revenue in Gene Delivery System Business (2020-2025)
7.2.5 Novartis Recent Development
7.3 Gilead Sciences
7.3.1 Gilead Sciences Company Details
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Gene Delivery System Introduction
7.3.4 Gilead Sciences Revenue in Gene Delivery System Business (2020-2025)
7.3.5 Gilead Sciences Recent Development
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Company Details
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Gene Delivery System Introduction
7.4.4 Sarepta Therapeutics Revenue in Gene Delivery System Business (2020-2025)
7.4.5 Sarepta Therapeutics Recent Development
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Company Details
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Gene Delivery System Introduction
7.5.4 Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2020-2025)
7.5.5 Alnylam Pharmaceuticals Recent Development
7.6 Amgen
7.6.1 Amgen Company Details
7.6.2 Amgen Business Overview
7.6.3 Amgen Gene Delivery System Introduction
7.6.4 Amgen Revenue in Gene Delivery System Business (2020-2025)
7.6.5 Amgen Recent Development
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Company Details
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Gene Delivery System Introduction
7.7.4 Spark Therapeutics Revenue in Gene Delivery System Business (2020-2025)
7.7.5 Spark Therapeutics Recent Development
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Company Details
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Gene Delivery System Introduction
7.8.4 Akcea Therapeutics Revenue in Gene Delivery System Business (2020-2025)
7.8.5 Akcea Therapeutics Recent Development
7.9 Sunway Biotech
7.9.1 Sunway Biotech Company Details
7.9.2 Sunway Biotech Business Overview
7.9.3 Sunway Biotech Gene Delivery System Introduction
7.9.4 Sunway Biotech Revenue in Gene Delivery System Business (2020-2025)
7.9.5 Sunway Biotech Recent Development
7.10 SIBIONO
7.10.1 SIBIONO Company Details
7.10.2 SIBIONO Business Overview
7.10.3 SIBIONO Gene Delivery System Introduction
7.10.4 SIBIONO Revenue in Gene Delivery System Business (2020-2025)
7.10.5 SIBIONO Recent Development
7.11 AnGes
7.11.1 AnGes Company Details
7.11.2 AnGes Business Overview
7.11.3 AnGes Gene Delivery System Introduction
7.11.4 AnGes Revenue in Gene Delivery System Business (2020-2025)
7.11.5 AnGes Recent Development
7.12 Orchard Therapeutics
7.12.1 Orchard Therapeutics Company Details
7.12.2 Orchard Therapeutics Business Overview
7.12.3 Orchard Therapeutics Gene Delivery System Introduction
7.12.4 Orchard Therapeutics Revenue in Gene Delivery System Business (2020-2025)
7.12.5 Orchard Therapeutics Recent Development
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Company Details
7.13.2 Human Stem Cells Institute Business Overview
7.13.3 Human Stem Cells Institute Gene Delivery System Introduction
7.13.4 Human Stem Cells Institute Revenue in Gene Delivery System Business (2020-2025)
7.13.5 Human Stem Cells Institute Recent Development
7.14 Adaptimmune
7.14.1 Adaptimmune Company Details
7.14.2 Adaptimmune Business Overview
7.14.3 Adaptimmune Gene Delivery System Introduction
7.14.4 Adaptimmune Revenue in Gene Delivery System Business (2020-2025)
7.14.5 Adaptimmune Recent Development
7.15 Krystal Biotech
7.15.1 Krystal Biotech Company Details
7.15.2 Krystal Biotech Business Overview
7.15.3 Krystal Biotech Gene Delivery System Introduction
7.15.4 Krystal Biotech Revenue in Gene Delivery System Business (2020-2025)
7.15.5 Krystal Biotech Recent Development
7.16 Vertex Pharmaceuticals
7.16.1 Vertex Pharmaceuticals Company Details
7.16.2 Vertex Pharmaceuticals Business Overview
7.16.3 Vertex Pharmaceuticals Gene Delivery System Introduction
7.16.4 Vertex Pharmaceuticals Revenue in Gene Delivery System Business (2020-2025)
7.16.5 Vertex Pharmaceuticals Recent Development
7.17 CSL Behring
7.17.1 CSL Behring Company Details
7.17.2 CSL Behring Business Overview
7.17.3 CSL Behring Gene Delivery System Introduction
7.17.4 CSL Behring Revenue in Gene Delivery System Business (2020-2025)
7.17.5 CSL Behring Recent Development
8 Gene Delivery System Market Dynamics
8.1 Gene Delivery System Industry Trends
8.2 Gene Delivery System Market Drivers
8.3 Gene Delivery System Market Challenges
8.4 Gene Delivery System Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen Inc
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
Sibiono
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Novartis
Biogen
Adaptimmune
Krystal Biotech
Vertex Pharmaceuticals
CSL Behring
List of Tables
 Table 1. Global Gene Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Gene Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Market Gene Delivery System Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global Gene Delivery System Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 5. Global Gene Delivery System Revenue Share by Region (2020-2025)
 Table 6. Global Gene Delivery System Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 7. Global Gene Delivery System Revenue Share Forecast by Region (2026-2031)
 Table 8. Global Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
 Table 9. Global Gene Delivery System Revenue Market Share by Type (2020-2025)
 Table 10. Global Gene Delivery System Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 11. Global Gene Delivery System Revenue Market Share by Type (2026-2031)
 Table 12. Representative Players of Each Type
 Table 13. Global Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
 Table 14. Global Gene Delivery System Revenue Market Share by Application (2020-2025)
 Table 15. Global Gene Delivery System Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 16. Global Gene Delivery System Revenue Market Share by Application (2026-2031)
 Table 17. New Sources of Growth in Gene Delivery System Application
 Table 18. Global Gene Delivery System Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Gene Delivery System Market Share by Players (2020-2025)
 Table 20. Global Top Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System as of 2024)
 Table 21. Ranking of Global Top Gene Delivery System Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Gene Delivery System Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Gene Delivery System, Headquarters and Area Served
 Table 24. Global Key Players of Gene Delivery System, Product and Application
 Table 25. Global Key Players of Gene Delivery System, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. North America Gene Delivery System Revenue by Company (2020-2025) & (US$ Million)
 Table 28. North America Gene Delivery System Revenue Market Share by Company (2020-2025)
 Table 29. North America Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
 Table 30. North America Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Europe Gene Delivery System Revenue by Company (2020-2025) & (US$ Million)
 Table 32. Europe Gene Delivery System Revenue Market Share by Company (2020-2025)
 Table 33. Europe Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
 Table 34. Europe Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
 Table 35. China Gene Delivery System Revenue by Company (2020-2025) & (US$ Million)
 Table 36. China Gene Delivery System Revenue Market Share by Company (2020-2025)
 Table 37. China Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
 Table 38. China Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
 Table 39. Japan Gene Delivery System Revenue by Company (2020-2025) & (US$ Million)
 Table 40. Japan Gene Delivery System Revenue Market Share by Company (2020-2025)
 Table 41. Japan Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
 Table 42. Japan Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
 Table 43. Biogen Company Details
 Table 44. Biogen Business Overview
 Table 45. Biogen Gene Delivery System Product
 Table 46. Biogen Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 47. Biogen Recent Development
 Table 48. Novartis Company Details
 Table 49. Novartis Business Overview
 Table 50. Novartis Gene Delivery System Product
 Table 51. Novartis Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 52. Novartis Recent Development
 Table 53. Gilead Sciences Company Details
 Table 54. Gilead Sciences Business Overview
 Table 55. Gilead Sciences Gene Delivery System Product
 Table 56. Gilead Sciences Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 57. Gilead Sciences Recent Development
 Table 58. Sarepta Therapeutics Company Details
 Table 59. Sarepta Therapeutics Business Overview
 Table 60. Sarepta Therapeutics Gene Delivery System Product
 Table 61. Sarepta Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 62. Sarepta Therapeutics Recent Development
 Table 63. Alnylam Pharmaceuticals Company Details
 Table 64. Alnylam Pharmaceuticals Business Overview
 Table 65. Alnylam Pharmaceuticals Gene Delivery System Product
 Table 66. Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 67. Alnylam Pharmaceuticals Recent Development
 Table 68. Amgen Company Details
 Table 69. Amgen Business Overview
 Table 70. Amgen Gene Delivery System Product
 Table 71. Amgen Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 72. Amgen Recent Development
 Table 73. Spark Therapeutics Company Details
 Table 74. Spark Therapeutics Business Overview
 Table 75. Spark Therapeutics Gene Delivery System Product
 Table 76. Spark Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 77. Spark Therapeutics Recent Development
 Table 78. Akcea Therapeutics Company Details
 Table 79. Akcea Therapeutics Business Overview
 Table 80. Akcea Therapeutics Gene Delivery System Product
 Table 81. Akcea Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 82. Akcea Therapeutics Recent Development
 Table 83. Sunway Biotech Company Details
 Table 84. Sunway Biotech Business Overview
 Table 85. Sunway Biotech Gene Delivery System Product
 Table 86. Sunway Biotech Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 87. Sunway Biotech Recent Development
 Table 88. SIBIONO Company Details
 Table 89. SIBIONO Business Overview
 Table 90. SIBIONO Gene Delivery System Product
 Table 91. SIBIONO Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 92. SIBIONO Recent Development
 Table 93. AnGes Company Details
 Table 94. AnGes Business Overview
 Table 95. AnGes Gene Delivery System Product
 Table 96. AnGes Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 97. AnGes Recent Development
 Table 98. Orchard Therapeutics Company Details
 Table 99. Orchard Therapeutics Business Overview
 Table 100. Orchard Therapeutics Gene Delivery System Product
 Table 101. Orchard Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 102. Orchard Therapeutics Recent Development
 Table 103. Human Stem Cells Institute Company Details
 Table 104. Human Stem Cells Institute Business Overview
 Table 105. Human Stem Cells Institute Gene Delivery System Product
 Table 106. Human Stem Cells Institute Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 107. Human Stem Cells Institute Recent Development
 Table 108. Adaptimmune Company Details
 Table 109. Adaptimmune Business Overview
 Table 110. Adaptimmune Gene Delivery System Product
 Table 111. Adaptimmune Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 112. Adaptimmune Recent Development
 Table 113. Krystal Biotech Company Details
 Table 114. Krystal Biotech Business Overview
 Table 115. Krystal Biotech Gene Delivery System Product
 Table 116. Krystal Biotech Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 117. Krystal Biotech Recent Development
 Table 118. Vertex Pharmaceuticals Company Details
 Table 119. Vertex Pharmaceuticals Business Overview
 Table 120. Vertex Pharmaceuticals Gene Delivery System Product
 Table 121. Vertex Pharmaceuticals Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 122. Vertex Pharmaceuticals Recent Development
 Table 123. CSL Behring Company Details
 Table 124. CSL Behring Business Overview
 Table 125. CSL Behring Gene Delivery System Product
 Table 126. CSL Behring Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
 Table 127. CSL Behring Recent Development
 Table 128. Gene Delivery System Market Trends
 Table 129. Gene Delivery System Market Drivers
 Table 130. Gene Delivery System Market Challenges
 Table 131. Gene Delivery System Market Restraints
 Table 132. Research Programs/Design for This Report
 Table 133. Key Data Information from Secondary Sources
 Table 134. Key Data Information from Primary Sources


List of Figures
 Figure 1. Gene Delivery System Product Picture
 Figure 2. Global Gene Delivery System Market Share by Type: 2024 VS 2031
 Figure 3. Viral Gene Delivery System Features
 Figure 4. Non-viral Gene Delivery System Features
 Figure 5. Global Gene Delivery System Market Share by Application: 2024 VS 2031
 Figure 6. Neurological Diseases
 Figure 7. Cancer
 Figure 8. Others
 Figure 9. Gene Delivery System Report Years Considered
 Figure 10. Global Gene Delivery System Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 11. Global Gene Delivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Gene Delivery System Revenue Market Share by Region: 2020 VS 2024
 Figure 13. North America Gene Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 14. Europe Gene Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 15. China Gene Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 16. Japan Gene Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 17. Global Gene Delivery System Market Share by Players in 2024
 Figure 18. Global Top Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Gene Delivery System Revenue in 2024
 Figure 20. North America Gene Delivery System Market Share by Type (2020-2025)
 Figure 21. North America Gene Delivery System Market Share by Application (2020-2025)
 Figure 22. Europe Gene Delivery System Market Share by Type (2020-2025)
 Figure 23. Europe Gene Delivery System Market Share by Application (2020-2025)
 Figure 24. China Gene Delivery System Market Share by Type (2020-2025)
 Figure 25. China Gene Delivery System Market Share by Application (2020-2025)
 Figure 26. Japan Gene Delivery System Market Share by Type (2020-2025)
 Figure 27. Japan Gene Delivery System Market Share by Application (2020-2025)
 Figure 28. Biogen Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 29. Novartis Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 30. Gilead Sciences Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 31. Sarepta Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 32. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 33. Amgen Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 34. Spark Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 35. Akcea Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 36. Sunway Biotech Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 37. SIBIONO Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 38. AnGes Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 39. Orchard Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 40. Human Stem Cells Institute Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 41. Adaptimmune Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 42. Krystal Biotech Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 43. Vertex Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 44. CSL Behring Revenue Growth Rate in Gene Delivery System Business (2020-2025)
 Figure 45. Bottom-up and Top-down Approaches for This Report
 Figure 46. Data Triangulation
 Figure 47. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4250

This license allows only one user to access the PDF.
Electronic (PDF)

$6375

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Gene Delivery or Gene Therapy Drug Market Research Report 2025
Global Gene based Therapy Medicinal Market Research Report 2024
Global Gene based Advanced Therapy Medicinal Market Research Report 2025
Gene Delivery System Technology Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Delivery System for Gene Therapy Market Research Report 2025
Gene Therapy on Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene based Advanced Therapy Medical Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Gene Therapy Market Research Report 2025
Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Gene Therapy on Neurological Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy in Cardiovascular Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Therapy For Cancer Market Research Report 2024
Global Gene Therapies for Cancer Treatment Market Research Report 2024
Global Gene Therapy On Cardiovascular Disease Market Research Report 2025
Global Gene Delivery Technologies Market Research Report 2024
Global Cell and Gene Therapy Market Research Report 2024

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions